John Hancock Disciplined Value Select ETF
JDVL - ETF AI Analysis
Top Page
John Hancock Disciplined Value Select ETF (JDVL)
JDVL, the John Hancock Disciplined Value Select ETF, earns a solid overall rating thanks to several strong core holdings like Microsoft, Gilead Sciences, and Quest Diagnostics, which show robust financial performance, positive earnings outlooks, and supportive technical trends that underpin long-term growth potential. Amazon and Visa also add strength through growth in cloud, AI, and payments, though their premium valuations and some short-term technical weakness, along with leveraged names like Philip Morris and Cencora, introduce risk. The main risk factor is the fund’s exposure to several companies with high leverage or rich valuations, which could make the ETF more sensitive to market downturns or shifts in investor sentiment.
JDVL vs. SPDR S&P 500 ETF (SPY)
- AUM
- 1.02B
- Region
- North America
- Expense Ratio
- 0.56%
- Beta
- 0.82
- Issuer
- John Hancock
- Inception Date
- Aug 06, 2025
- Dividend Yield
- 1.45%
- Asset Class
- Equity
- Index Tracked
- No Underlying Index
JDVL Summary
JDVL is the John Hancock Disciplined Value Select ETF, an actively managed fund that focuses on large U.S. companies that appear undervalued. It doesn’t track a specific index, but follows a value investing theme, aiming to find solid businesses whose stock prices may be temporarily out of favor. The fund holds well-known names like Amazon and Microsoft, along with companies from financials, health care, and other sectors, giving investors broad diversification within large-cap stocks. Someone might invest for long-term growth from these value opportunities, but should know the share price can go up and down with the overall stock market.
How much will it cost me?
This ETF has an expense ratio of 0.56%, which means you’ll pay about $5.60 per year for every $1,000 you invest. That’s higher than the average low-cost index ETF because JDVL is actively managed, with professionals selecting and researching individual value stocks.
What would affect this ETF?
JDVL could benefit if the U.S. economy stays resilient, value stocks come back into favor, and large tech and financial names like Amazon, Microsoft, and JPMorgan continue to grow, supporting its mix of sectors such as technology, health care, and financials. On the downside, a U.S. slowdown, rising interest rates that pressure banks and growth companies, or new regulations affecting big tech, financials, or health care firms could weigh on the fund’s future performance.
JDVL Top 10 Holdings
JDVL leans heavily on U.S. large-cap value with a clear tilt toward financials, health care, and a dash of Big Tech. Microsoft and Amazon are the tech engines, both rising and giving the fund some growth flair despite its value label. In health care, Gilead and Quest Diagnostics have been steady climbers, quietly boosting returns, while Cencora is losing steam and acting as a small drag. US Foods and Philip Morris add consumer exposure, with US Foods in particular powering ahead. Overall, it’s a U.S.-centric, sector-diversified portfolio with a few standout winners doing the heavy lifting.
| Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| Amazon | 8.06% | $83.47M | $2.89T | 12.24% | 71Outperform | |
| Microsoft | 6.57% | $68.04M | $3.88T | 4.09% | 79Outperform | |
| JPMorgan Chase | 4.43% | $45.88M | $910.40B | 11.86% | 72Outperform | |
| US Foods Holding | 4.19% | $43.37M | $23.24B | 50.35% | 74Outperform | |
| NXP Semiconductors | 3.53% | $36.50M | $67.37B | 31.74% | 70Neutral | |
| Philip Morris | 3.25% | $33.67M | $306.53B | 28.24% | 61Neutral | |
| Visa | 3.22% | $33.32M | $779.42B | 26.68% | 70Outperform | |
| Gilead Sciences | 3.18% | $32.92M | $208.31B | 34.25% | 78Outperform | |
| Cencora | 2.83% | $29.31M | $66.67B | -1.76% | 70Neutral | |
| Quest Diagnostics | 2.75% | $28.49M | $28.57B | 38.39% | 79Outperform |
JDVL Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For JDVL, the sentiment is Positive. The current price of 31.79 is above the 20-day moving average (MA) of 31.70, above the 50-day MA of 31.71, and above the 200-day MA of 30.43, indicating a bullish trend. The MACD of 0.00 indicates Negative momentum. The RSI at 51.22 is Neutral, neither overbought nor oversold. The STOCH value of 54.88 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JDVL.
JDVL Peer Comparison
Comparison Results
| Name | Price | Price Target | AUM | Expense Ratio | Overall Rating |
|---|---|---|---|---|---|
| $31.79 | $35.00(10.10% Upside) | $1.02B | 0.56% | 71Outperform | |
| $84.64 | $96.67(14.21% Upside) | $7.62B | 0.44% | 71Outperform | |
| $42.11 | $48.33(14.77% Upside) | $7.69B | 0.21% | 73Outperform | |
| $43.75 | $49.30(12.68% Upside) | $3.78B | 0.18% | 72Outperform | |
| $71.14 | $79.69(12.03% Upside) | $2.18B | 0.39% | 72Outperform | |
| $49.55 | $58.80(18.67% Upside) | $1.63B | 0.15% | 72Outperform |
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| JDVL | John Hancock Disciplined Value Select ETF | 31.79 | 5.91 | 22.82% | |
| JAVA | JPMorgan Active Value ETF | 84.64 | 16.64 | 24.48% | |
| DFLV | Dimensional US Large Cap Value ETF | 42.11 | 9.94 | 30.89% | |
| FELV | Fidelity Enhanced Large Cap Value ETF | 43.75 | 10.89 | 33.15% | |
| DSTL | Distillate US Fundamental Stability & Value ETF | 71.14 | 15.04 | 26.80% | |
| SEIV | SEI Enhanced U.S. Large Cap Value Factor ETF | 49.55 | 11.07 | 28.76% |
This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
